Pure Global AI
CDSCO UID MFG/MD/2018/000029_efbbe464ae359c0d50f3d7484f5ec327_5503f6e2144c384af1df404894498ef5

Drug of Abuse Rapid Test- Phencyclidine-25mg/ml

Meril Diagnostics Pvt. Ltd.Device Class Class CIndia CDSCOBrand: Merilisa
VerifiedCDSCO · official registry
Registration details
UID
MFG/MD/2018/000029_efbbe464ae359c0d50f3d7484f5ec327_5503f6e2144c384af1df404894498ef5
Device class
Class C
Brand name
Merilisa
Approving authority
Central Drug Standards Control Organization, Ahmedabad
Product information
Drug of Abuse(Merilisa)Rapid Test Phencyclidine-25mg/ml (Merilisa) is a qualitative immunoassay intended to be used to detect the presence of Phencyclidine drugs and/or their metabolites at or above the specified cut of level in human urine in a single assay
About this record

Drug of Abuse Rapid Test- Phencyclidine-25mg/ml is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000029_efbbe464ae359c0d50f3d7484f5ec327_5503f6e2144c384af1df404894498ef5. This device is marketed under the brand name Merilisa. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.